Perrigo Company plc
Perrigo Company plc (PRGO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRGO · as of Jun 8, 2026
Key Statistics
Explore Perrigo Company plc Data
prgo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 36 · Buy rate: 38.9%
The PRGO analyst consensus is Hold, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $36.20, representing +211.67% upside from the current price of $11.62.
Competitors & Peers
prgo competitorsPRGO
ATEC
BHC
FOLD
HCM
HTFLStock Performance
Full HistoryAbout Perrigo Company plc
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. Th…
what is perrigo company plc · prgo stock overview · perrigo company plc company profile · who is perrigo company plc ceo · prgo NYSE · perrigo company plc headquarters · perrigo company plc business segments
About Stock Overview & Key Data
Perrigo Company plc (PRGO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Dec 17, 1991. As of the latest trading session, PRGO stock price is $11.62, with a market capitalization of $1.6B. The stock has returned -58.62% over the past 12 months and -22.20% year-to-date.
According to 36 Wall Street analysts, the consensus rating for Perrigo Company plc stock is Hold, with an average 12-month price target of $36.20. In fiscal year 2025, Perrigo Company plc reported revenue of $4.3B and net income of -$1.4B. For detailed data — including Perrigo Company plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Perrigo Company plc (PRGO) stock price is $11.62. The stock is traded on NYSE under the ticker symbol PRGO. The 52-week range is $9.23 – $28.44.